{"id":"aleph-influenza-vaccine","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or erythema"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Low-grade fever"}]},"_chembl":{"chemblId":"CHEMBL2109042","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an influenza vaccine, it contains inactivated or attenuated influenza virus antigens that train the adaptive immune system to recognize and respond to circulating influenza strains. Upon exposure to wild-type influenza virus, vaccinated individuals mount a faster and more robust immune response, reducing infection severity and transmission risk.","oneSentence":"Aleph influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:42:10.914Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT04833101","phase":"PHASE4","title":"Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine","status":"COMPLETED","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2021-04-07","conditions":"COVID-19","enrollment":120},{"nctId":"NCT01758185","phase":"PHASE4","title":"Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine","status":"COMPLETED","sponsor":"Beijing Center for Disease Control and Prevention","startDate":"2011-08","conditions":"Healthy","enrollment":3308}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Aleph influenza vaccine","genericName":"Aleph influenza vaccine","companyName":"Beijing Center for Disease Control and Prevention","companyId":"beijing-center-for-disease-control-and-prevention","modality":"Biologic","firstApprovalDate":"","aiSummary":"Aleph influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains. Used for Influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}